Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

bmiMD vs Telos Rx

Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Telos Rx a 85. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

bmiMD

#8 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full bmiMD review →
VS

Telos Rx

#22 · Grade A- · Great Deal

Est. first month

$145/mo

Save ~89% vs brand-name
Get this deal Full Telos Rx review →

The verdict

Better value: bmiMD

bmiMD takes it on Value Score, 89 to 85 an est. $99/mo first month, with no teaser step-up baked in. Telos Rx isn't out of it: Committed shoppers willing to lock in 6–12 months to unlock genuinely rock-bottom compounded pricing, who want oral or microdosed options on one platform.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealbmiMDTelos Rx
Value Score89 (A)85 (A-)
Est. first month$99/mo$145/mo
Save vs brand-name~93%~89%
Semaglutide$99/moFrom $49/mo (annual)
Tirzepatide$139/moFrom $99/mo (annual)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesNot publicly listed

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
86
bmiMD: 95. Telos Rx: 86.
84
No Teaser-Rate Bait
74
bmiMD: 84. Telos Rx: 74.
98
Nationwide Availability
74
bmiMD: 98. Telos Rx: 74.
94
Both Molecules
96
bmiMD: 94. Telos Rx: 96.
82
Easy Cancellation
80
bmiMD: 82. Telos Rx: 80.
70
Reputation
86
bmiMD: 70. Telos Rx: 86.

bmiMD

Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.

Why it's a deal

  • $99 flat semaglutide and a low $139 tirzepatide
  • Available in all 50 states
  • Both molecules priced up front

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Thin public track record; no oral or brand-name option

Telos Rx

Among the lowest published GLP-1 entry prices anywhere — microdosed semaglutide from $49/mo and tirzepatide from $99/mo — on a deep needle-free and oral menu, but the rock-bottom rates require a 6–12 month commitment, so the real month-to-month cost runs higher.

Why it's a deal

  • Among the lowest published GLP-1 entry prices — microdosed sema from $49/mo and tirzepatide from $99/mo on annual plans
  • Deep catalog including needle-free intranasal and oral/microdosed GLP-1 options
  • LegitScript-certified and HIPAA-compliant, with HSA/FSA accepted and free 48-hour shipping

The fine print

  • Rock-bottom prices require a 6–12 month commitment — real month-to-month cost is much higher ($145/$199/$399 first month)
  • All compounded, not FDA-approved — and the research-grade peptides in its catalog have limited evidence
  • Peptide and HRT pricing is hidden until you complete intake
  • State list is not publicly published — confirm coverage before you sign up
Get the bmiMD deal Get the Telos Rx deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.